Cargando…

Traditional and complementary medicine use among cancer patients in Nepal: a cross-sectional survey

BACKGROUND: Traditional and complementary medicine (T&CM) is commonly used in South Asian countries such as Nepal. There are various causes and contributing factors for patients with cancer to consider using T&CM. However, little is known about the use of T&CM among the cancer population...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Soo Jeung, Kunwor, Sangita Karki, Im, Hyea Bin, Hwang, Jung Hye, Choi, Dain, Han, Dongwoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925159/
https://www.ncbi.nlm.nih.gov/pubmed/35291988
http://dx.doi.org/10.1186/s12906-022-03555-8
_version_ 1784670010540556288
author Choi, Soo Jeung
Kunwor, Sangita Karki
Im, Hyea Bin
Hwang, Jung Hye
Choi, Dain
Han, Dongwoon
author_facet Choi, Soo Jeung
Kunwor, Sangita Karki
Im, Hyea Bin
Hwang, Jung Hye
Choi, Dain
Han, Dongwoon
author_sort Choi, Soo Jeung
collection PubMed
description BACKGROUND: Traditional and complementary medicine (T&CM) is commonly used in South Asian countries such as Nepal. There are various causes and contributing factors for patients with cancer to consider using T&CM. However, little is known about the use of T&CM among the cancer population in this region. METHODS: The study followed a cross-sectional design using a structured survey questionnaire. Survey participants were recruited from two National hospitals in Kathmandu, Nepal. The survey instrument comprised 30 questions, including variables on demographics, use of T&CM, and perceived level of disease severity, and cancer treatment. Chi-square test and logistic regression were used for data analysis using SPSS ver. 23.0. RESULTS: Of 908 participants, 31.6% used one or more modalities of T&CM after a cancer diagnosis. The most commonly used T&CM was Ayurveda (46.5%), followed by yoga (32.4%). About 46% of T&CM users discussed their use with their doctors. The main source of information on T&CM was their family members and relatives (55.7%). Cancer type (head and neck cancer OR: 2.30, CI: 1.23–4.29; abdominal cancer OR: 2.69, CI: 1.47–4.95; lung cancer OR: 5.88, CI: 2.69–12.89), cancer stage (Stage I OR: 1.92¸CI: 1.14–3.25; Stage II OR: 1.76, CI: 1.06–2.94), and the patients’ self-rated disease severity (high perceived severity OR: 1.50, CI: 1.05–2.16) were strong predictors of T&CM use. CONCLUSION: This study underlined that despite the widespread use of T&CM among cancer patients in Nepal, most patients obtained information on T&CM from informal sources and did not disclose their use to physicians. To ensure the safe use of T&CM modalities, physicians should integrate questions on T&CM use into routine patient assessments in order to facilitate active communication and improve the quality of care.
format Online
Article
Text
id pubmed-8925159
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89251592022-03-23 Traditional and complementary medicine use among cancer patients in Nepal: a cross-sectional survey Choi, Soo Jeung Kunwor, Sangita Karki Im, Hyea Bin Hwang, Jung Hye Choi, Dain Han, Dongwoon BMC Complement Med Ther Research BACKGROUND: Traditional and complementary medicine (T&CM) is commonly used in South Asian countries such as Nepal. There are various causes and contributing factors for patients with cancer to consider using T&CM. However, little is known about the use of T&CM among the cancer population in this region. METHODS: The study followed a cross-sectional design using a structured survey questionnaire. Survey participants were recruited from two National hospitals in Kathmandu, Nepal. The survey instrument comprised 30 questions, including variables on demographics, use of T&CM, and perceived level of disease severity, and cancer treatment. Chi-square test and logistic regression were used for data analysis using SPSS ver. 23.0. RESULTS: Of 908 participants, 31.6% used one or more modalities of T&CM after a cancer diagnosis. The most commonly used T&CM was Ayurveda (46.5%), followed by yoga (32.4%). About 46% of T&CM users discussed their use with their doctors. The main source of information on T&CM was their family members and relatives (55.7%). Cancer type (head and neck cancer OR: 2.30, CI: 1.23–4.29; abdominal cancer OR: 2.69, CI: 1.47–4.95; lung cancer OR: 5.88, CI: 2.69–12.89), cancer stage (Stage I OR: 1.92¸CI: 1.14–3.25; Stage II OR: 1.76, CI: 1.06–2.94), and the patients’ self-rated disease severity (high perceived severity OR: 1.50, CI: 1.05–2.16) were strong predictors of T&CM use. CONCLUSION: This study underlined that despite the widespread use of T&CM among cancer patients in Nepal, most patients obtained information on T&CM from informal sources and did not disclose their use to physicians. To ensure the safe use of T&CM modalities, physicians should integrate questions on T&CM use into routine patient assessments in order to facilitate active communication and improve the quality of care. BioMed Central 2022-03-15 /pmc/articles/PMC8925159/ /pubmed/35291988 http://dx.doi.org/10.1186/s12906-022-03555-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Choi, Soo Jeung
Kunwor, Sangita Karki
Im, Hyea Bin
Hwang, Jung Hye
Choi, Dain
Han, Dongwoon
Traditional and complementary medicine use among cancer patients in Nepal: a cross-sectional survey
title Traditional and complementary medicine use among cancer patients in Nepal: a cross-sectional survey
title_full Traditional and complementary medicine use among cancer patients in Nepal: a cross-sectional survey
title_fullStr Traditional and complementary medicine use among cancer patients in Nepal: a cross-sectional survey
title_full_unstemmed Traditional and complementary medicine use among cancer patients in Nepal: a cross-sectional survey
title_short Traditional and complementary medicine use among cancer patients in Nepal: a cross-sectional survey
title_sort traditional and complementary medicine use among cancer patients in nepal: a cross-sectional survey
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925159/
https://www.ncbi.nlm.nih.gov/pubmed/35291988
http://dx.doi.org/10.1186/s12906-022-03555-8
work_keys_str_mv AT choisoojeung traditionalandcomplementarymedicineuseamongcancerpatientsinnepalacrosssectionalsurvey
AT kunworsangitakarki traditionalandcomplementarymedicineuseamongcancerpatientsinnepalacrosssectionalsurvey
AT imhyeabin traditionalandcomplementarymedicineuseamongcancerpatientsinnepalacrosssectionalsurvey
AT hwangjunghye traditionalandcomplementarymedicineuseamongcancerpatientsinnepalacrosssectionalsurvey
AT choidain traditionalandcomplementarymedicineuseamongcancerpatientsinnepalacrosssectionalsurvey
AT handongwoon traditionalandcomplementarymedicineuseamongcancerpatientsinnepalacrosssectionalsurvey